As of 2025-07-17, the Relative Valuation of Clearpoint Neuro Inc (CLPT) is (25.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 11.33 USD, the upside of Clearpoint Neuro Inc based on Relative Valuation is -328.7%.
The range of the Relative Valuation is (26.08) - (26.79) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.5x - 43.2x | 37.0x |
| Forward P/E multiples | 33.0x - 36.4x | 33.5x |
| Fair Price | (26.08) - (26.79) | (25.91) |
| Upside | -330.2% - -336.4% | -328.7% |
| Date | P/E |
| 2025-07-16 | -15.40 |
| 2025-07-15 | -15.16 |
| 2025-07-14 | -16.11 |
| 2025-07-11 | -15.50 |
| 2025-07-10 | -16.26 |
| 2025-07-09 | -16.65 |
| 2025-07-08 | -15.99 |
| 2025-07-07 | -16.04 |
| 2025-07-03 | -15.91 |
| 2025-07-02 | -15.35 |
| 2025-07-01 | -15.31 |
| 2025-06-30 | -16.23 |
| 2025-06-27 | -16.04 |
| 2025-06-26 | -16.34 |
| 2025-06-25 | -15.99 |
| 2025-06-24 | -15.81 |
| 2025-06-23 | -15.44 |
| 2025-06-20 | -15.31 |
| 2025-06-18 | -15.29 |
| 2025-06-17 | -15.19 |
| 2025-06-16 | -15.77 |
| 2025-06-13 | -15.69 |
| 2025-06-12 | -16.42 |
| 2025-06-11 | -17.47 |
| 2025-06-10 | -18.07 |
| 2025-06-09 | -18.10 |
| 2025-06-06 | -18.94 |
| 2025-06-05 | -17.44 |
| 2025-06-04 | -17.66 |
| 2025-06-03 | -17.21 |
| 2025-06-02 | -16.03 |
| 2025-05-30 | -16.06 |
| 2025-05-29 | -16.27 |
| 2025-05-28 | -16.44 |
| 2025-05-27 | -17.05 |
| 2025-05-23 | -16.16 |
| 2025-05-22 | -16.42 |
| 2025-05-21 | -16.53 |
| 2025-05-20 | -17.39 |
| 2025-05-19 | -17.84 |
| 2025-05-16 | -17.92 |
| 2025-05-15 | -17.57 |
| 2025-05-14 | -16.90 |
| 2025-05-13 | -19.31 |
| 2025-05-12 | -18.54 |
| 2025-05-09 | -19.18 |
| 2025-05-08 | -19.37 |
| 2025-05-07 | -18.07 |
| 2025-05-06 | -17.82 |
| 2025-05-05 | -18.87 |